AUTHOREA
Log in Sign Up Browse Preprints
LOG IN SIGN UP
Natalija Novak
Natalija Novak

Public Documents 3
COVID-19 vaccines and the role of other potential allergenic components different fro...
Natalija Novak
Cezmi Akdis

Natalija Novak

and 2 more

January 25, 2021
COVID-19 vaccines and the role of other potential allergenic components different from PEG. A reply to: “Other excipients than PEG might cause serious hypersensitivity reactions in COVID-19 vaccines”
“COVID-19 vaccine anaphylaxis: IgE, complement or what else?”
Beatriz Cabanillas
Cezmi Akdis

Beatriz Cabanillas

and 2 more

December 24, 2020
Title: COVID-19 vaccine anaphylaxis: IgE, complement or what else? A reply to: “COVID-19 vaccine anaphylaxis: PEG or not?”
SARS-CoV-2, COVID-19, skin and vascular system - what do we know so far?
Natalija Novak
Wenming Peng

Natalija Novak

and 8 more

June 10, 2020
The pandemic condition Coronavirus-disease (COVID-19), caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can take asymptomatic, mild, moderate, and severe courses. COVID-19 affects primarily the respiratory airways leading to dry cough, fever, myalgia, headache, fatigue, and diarrhea and can end up in interstitial pneumonia and severe respiratory failure. Different clinical symptoms caused by involvement of organs outside the respiratory system have been also described. Interestingly, reports about the manifestation of various skin lesions and lesions of the vascular system in some subgroups of SARS-CoV-2 positive patients as such features outside the respiratory sphere, are rapidly emerging. However, knowledge about prevalence and pattern of skin involvement, time of onset, predilection, and its direct or indirect relation to SARS-CoV-2 is still limited. In order to update information gained, we provide a systematic overview of the skin lesions described in COVID-19 patients, discuss potential causative factors and describe differential diagnostic evaluations.

| Powered by Authorea.com

  • Home